Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADIS-PE: Extended Warfarin vs Placebo in Idiopathic Pulmonary Embolism
NCT00740883Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jul 2007
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of warfarin in pulmonary embolism (PE), sponsored by Centre Hospitalier Universitaire de Brest. Started Jul 2007; status: completed.
02
Drugs
warfarin
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT00740883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00740883.